Controversies in the surgical treatment of non-small cell lung cancer

S. C. Tomaszek, Dennis A Wigle

Research output: Contribution to journalArticle

Abstract

Lung cancer continues to be one of the most frequent cancer-related causes of death worldwide. Despite the general acknowledgment that surgical resection is the most effective treatment in non-small cell lung cancer, there remains significant areas of controversy in the application of surgical resection. Appropriate patient selection must be based on the assessment of benefits and risks involved for the patient. This decision, however, is multifactorial and approached differently by surgeons worldwide based on a combination of training, clinical practice experience and available research data. Efficacy of competing non-invasive and invasive mediastinal staging modalities, the extent of mediastinal staging and surgical resection, as well as whether there is a role for surgery in locally advanced or metastatic lung cancer are further controversial topics addressed in this review.

Original languageEnglish (US)
Pages (from-to)33-43
Number of pages11
JournalMinerva Pneumologica
Volume49
Issue number1
StatePublished - Mar 2010

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Patient Selection
Cause of Death
Therapeutics
Research
Neoplasms
Surgeons

Keywords

  • Carcinoma, non-small-cell lung, diagnosis
  • Carcinoma, non-small-cell lung, surgery
  • Thorax, surgery

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Controversies in the surgical treatment of non-small cell lung cancer. / Tomaszek, S. C.; Wigle, Dennis A.

In: Minerva Pneumologica, Vol. 49, No. 1, 03.2010, p. 33-43.

Research output: Contribution to journalArticle

@article{ef31ac1d0ee14ae78f2ce6efedaebe63,
title = "Controversies in the surgical treatment of non-small cell lung cancer",
abstract = "Lung cancer continues to be one of the most frequent cancer-related causes of death worldwide. Despite the general acknowledgment that surgical resection is the most effective treatment in non-small cell lung cancer, there remains significant areas of controversy in the application of surgical resection. Appropriate patient selection must be based on the assessment of benefits and risks involved for the patient. This decision, however, is multifactorial and approached differently by surgeons worldwide based on a combination of training, clinical practice experience and available research data. Efficacy of competing non-invasive and invasive mediastinal staging modalities, the extent of mediastinal staging and surgical resection, as well as whether there is a role for surgery in locally advanced or metastatic lung cancer are further controversial topics addressed in this review.",
keywords = "Carcinoma, non-small-cell lung, diagnosis, Carcinoma, non-small-cell lung, surgery, Thorax, surgery",
author = "Tomaszek, {S. C.} and Wigle, {Dennis A}",
year = "2010",
month = "3",
language = "English (US)",
volume = "49",
pages = "33--43",
journal = "Minerva Pneumologica",
issn = "0026-4954",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Controversies in the surgical treatment of non-small cell lung cancer

AU - Tomaszek, S. C.

AU - Wigle, Dennis A

PY - 2010/3

Y1 - 2010/3

N2 - Lung cancer continues to be one of the most frequent cancer-related causes of death worldwide. Despite the general acknowledgment that surgical resection is the most effective treatment in non-small cell lung cancer, there remains significant areas of controversy in the application of surgical resection. Appropriate patient selection must be based on the assessment of benefits and risks involved for the patient. This decision, however, is multifactorial and approached differently by surgeons worldwide based on a combination of training, clinical practice experience and available research data. Efficacy of competing non-invasive and invasive mediastinal staging modalities, the extent of mediastinal staging and surgical resection, as well as whether there is a role for surgery in locally advanced or metastatic lung cancer are further controversial topics addressed in this review.

AB - Lung cancer continues to be one of the most frequent cancer-related causes of death worldwide. Despite the general acknowledgment that surgical resection is the most effective treatment in non-small cell lung cancer, there remains significant areas of controversy in the application of surgical resection. Appropriate patient selection must be based on the assessment of benefits and risks involved for the patient. This decision, however, is multifactorial and approached differently by surgeons worldwide based on a combination of training, clinical practice experience and available research data. Efficacy of competing non-invasive and invasive mediastinal staging modalities, the extent of mediastinal staging and surgical resection, as well as whether there is a role for surgery in locally advanced or metastatic lung cancer are further controversial topics addressed in this review.

KW - Carcinoma, non-small-cell lung, diagnosis

KW - Carcinoma, non-small-cell lung, surgery

KW - Thorax, surgery

UR - http://www.scopus.com/inward/record.url?scp=77953585946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953585946&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953585946

VL - 49

SP - 33

EP - 43

JO - Minerva Pneumologica

JF - Minerva Pneumologica

SN - 0026-4954

IS - 1

ER -